Covered recipient · General Payments record
AMANDA BAXTER
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2025
$295.88
- Reported across 8 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $295.88 | 8 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABIOMED | $137.55 | 1 |
| Retrophin, Inc. | $71.49 | 3 |
| Novo Nordisk AS | $27.14 | 1 |
| Ultragenyx Pharmaceutical Inc. | $23.86 | 1 |
| Otsuka America Pharmaceutical, Inc. | $20.71 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $15.13 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2025 | $295.88 | 8 |
Payment records · PY2025 (8)
Ordering applied by this site (paying entity, then date) · record values are shown as CMS published them
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABIOMED | $137.55 | 02/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1174955982 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $15.13 | 03/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1225461114 | CMS |
| Novo Nordisk Inc | $27.14 | 02/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188879564 | CMS |
| Otsuka America Pharmaceutical, Inc. | $20.71 | 03/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227582944 | CMS |
| Travere Therapeutics, Inc. | $27.87 | 03/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1244431330 | CMS |
| Travere Therapeutics, Inc. | $20.15 | 04/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1244431326 | CMS |
| Travere Therapeutics, Inc. | $23.47 | 05/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1244431328 | CMS |
| Ultragenyx Pharmaceutical Inc. | $23.86 | 03/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1253155161 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2025
- Source files
- Dataset page · Bulk file · PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.